EU RO PEAN SOCIETY O F CARDIOLOGY ®Original scientific paper Myocardial infarction in pregnancy and

P Brocklehurst1 and M Knight1 (on behalf of UKOSS) Aim: Cardiac disease is a leading cause of maternal death in the developed world, responsible for one-fifth of all maternal deaths in the UK. The aim of this study was to estimate the incidence of myocardial infarction (MI) in pregnancy and up to one week postpartum in the UK and describe risk factors, management and outcomes. Methods: A prospective population-based study with nested case control analysis used the UKObstetric Surveillance System to identify all women in the UK with MI in pregnancy (in the years 2005–2010). A control group of 1360 women was used for comparison. Multivariable unconditional logistic regression was conducted to identify potential risk factors for MI in pregnancy and calculate adjusted odds ratios with 95 % confidence intervals. Results: Twenty-five cases of MI in pregnancy were reported, giving an estimated incidence of 0.7 per 100,000 mater-nities (95%CI 0.5–1.1). Maternal age, smoking, hypertension, twin pregnancy and pre-eclampsia were independently associated with MI in pregnancy. Fifteen (60%) women underwent coronary angiography; nine (60%) had coronary atherosclerosis, three (21%) had coronary artery dissection, one (7%) had a coronary thrombus and two (13%) had normal coronary arteries. Nine women had angioplasty þ/ stenting and two were thrombolysed. No women died. Conclusions: Many risk factors are both recognisable and modifiable. Management of MI in pregnancy was highly variable indicating a clear need for further information regarding the safety and outcomes of different interventions. The addition of pregnancy status as a compulsory field in cardiac audit databases would enable routine collection of this information